I'm LongbridgeAI, I can summarize articles.Jefferies analyst Michael Leuchten maintained a Buy rating on AstraZeneca today and set a price target of £175.00.
According to TipRanks, Leuchten is an analyst with an average return of -3.1% and a 54.65% success rate. Leuchten covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and Roche Holding AG.
In addition to Jefferies, AstraZeneca also received a Buy from Bernstein’s Justin Smith in a report issued on November 3. However, on November 6, Deutsche Bank maintained a Hold rating on AstraZeneca (LSE: AZN).
